Matches in SemOpenAlex for { <https://semopenalex.org/work/W3087568978> ?p ?o ?g. }
- W3087568978 endingPage "1624" @default.
- W3087568978 startingPage "1616" @default.
- W3087568978 abstract "Abstract Background To report the long-term outcomes of a phase III trial designed to test two hypotheses: (1) elective nodal irradiation (ENI) is superior to conventional field irradiation (CFI), and (2) chemoradiotherapy plus erlotinib is superior to chemoradiotherapy in locally advanced oesophageal squamous cell cancer (ESCC). Methods Patients with locally advanced ESCC were randomly assigned (1:1:1:1 ratio) to one of the four groups: A: radiotherapy adoption of ENI with two cycles of concurrent TP chemotherapy (paclitaxel and cisplatin) plus erlotinib; B: radiotherapy adoption of ENI with two cycles of concurrent TP; C: radiotherapy adoption of CFI with two cycles of concurrent TP plus erlotinib and D: radiotherapy adoption of CFI with two cycles of concurrent TP. A total of 60 Gy of radiation doses was delivered over 30 fractions. We explored the impact of epidermal growth factor receptor (EGFR) expression on the efficacy of erlotinib plus chemoradiotherapy. Results A total of 352 patients (88 assigned to each treatment group) were enrolled. The 5-year survival rates were 44.9%, 34.8%, 33.8% and 19.6% in groups A, B, C and D, respectively ( P = 0.013). ENI significantly improved OS compared with standard CFI (median, 38.5 vs 22.6 months; HR, 0.74; P = 0.018). The addition of erlotinib significantly improved OS (median, 39.4 vs 27.4 months; HR, 0.75; P = 0.025). Patients with overexpressing EGFR treated with erlotinib had a better OS and PFS than those without erlotinib. Conclusions Concurrent chemoradiotherapy with ENI and/or erlotinib improved long-term survival in locally advanced ESCC. Clinical trial registration Trial registration: NCT00686114." @default.
- W3087568978 created "2020-09-25" @default.
- W3087568978 creator A5008581844 @default.
- W3087568978 creator A5012655191 @default.
- W3087568978 creator A5017351585 @default.
- W3087568978 creator A5017941291 @default.
- W3087568978 creator A5018176440 @default.
- W3087568978 creator A5020075019 @default.
- W3087568978 creator A5021660017 @default.
- W3087568978 creator A5022193491 @default.
- W3087568978 creator A5033639682 @default.
- W3087568978 creator A5037140847 @default.
- W3087568978 creator A5040975337 @default.
- W3087568978 creator A5042675351 @default.
- W3087568978 creator A5050573989 @default.
- W3087568978 creator A5056623428 @default.
- W3087568978 creator A5060299728 @default.
- W3087568978 creator A5064878839 @default.
- W3087568978 creator A5074004084 @default.
- W3087568978 creator A5081887223 @default.
- W3087568978 creator A5082816966 @default.
- W3087568978 creator A5089474742 @default.
- W3087568978 date "2020-09-22" @default.
- W3087568978 modified "2023-10-13" @default.
- W3087568978 title "Chemoradiotherapy with extended nodal irradiation and/or erlotinib in locally advanced oesophageal squamous cell cancer: long-term update of a randomised phase 3 trial" @default.
- W3087568978 cites W1966714873 @default.
- W3087568978 cites W1973840209 @default.
- W3087568978 cites W1974024530 @default.
- W3087568978 cites W1979044635 @default.
- W3087568978 cites W1979056477 @default.
- W3087568978 cites W1983287464 @default.
- W3087568978 cites W1996158185 @default.
- W3087568978 cites W1997900832 @default.
- W3087568978 cites W1999707014 @default.
- W3087568978 cites W2038914273 @default.
- W3087568978 cites W2042469467 @default.
- W3087568978 cites W2051250465 @default.
- W3087568978 cites W2063515380 @default.
- W3087568978 cites W2063867686 @default.
- W3087568978 cites W2064776982 @default.
- W3087568978 cites W2067682297 @default.
- W3087568978 cites W2073130801 @default.
- W3087568978 cites W2075141037 @default.
- W3087568978 cites W2118113452 @default.
- W3087568978 cites W2129138183 @default.
- W3087568978 cites W2144263975 @default.
- W3087568978 cites W2165311092 @default.
- W3087568978 cites W2166559675 @default.
- W3087568978 cites W2177996735 @default.
- W3087568978 cites W2274820688 @default.
- W3087568978 cites W2310242935 @default.
- W3087568978 cites W2394989507 @default.
- W3087568978 cites W2404069638 @default.
- W3087568978 cites W2416425543 @default.
- W3087568978 cites W2430320680 @default.
- W3087568978 cites W2496243685 @default.
- W3087568978 cites W2505837694 @default.
- W3087568978 cites W2512217706 @default.
- W3087568978 cites W2618723848 @default.
- W3087568978 cites W2733820327 @default.
- W3087568978 cites W2790015936 @default.
- W3087568978 cites W2808607186 @default.
- W3087568978 cites W2885945773 @default.
- W3087568978 cites W2889004312 @default.
- W3087568978 cites W2899048872 @default.
- W3087568978 cites W2909018638 @default.
- W3087568978 cites W2916257381 @default.
- W3087568978 cites W2917837889 @default.
- W3087568978 cites W2924582533 @default.
- W3087568978 cites W2939241793 @default.
- W3087568978 cites W2962714165 @default.
- W3087568978 cites W4236554935 @default.
- W3087568978 doi "https://doi.org/10.1038/s41416-020-01054-6" @default.
- W3087568978 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7686329" @default.
- W3087568978 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32958820" @default.
- W3087568978 hasPublicationYear "2020" @default.
- W3087568978 type Work @default.
- W3087568978 sameAs 3087568978 @default.
- W3087568978 citedByCount "15" @default.
- W3087568978 countsByYear W30875689782020 @default.
- W3087568978 countsByYear W30875689782021 @default.
- W3087568978 countsByYear W30875689782022 @default.
- W3087568978 countsByYear W30875689782023 @default.
- W3087568978 crossrefType "journal-article" @default.
- W3087568978 hasAuthorship W3087568978A5008581844 @default.
- W3087568978 hasAuthorship W3087568978A5012655191 @default.
- W3087568978 hasAuthorship W3087568978A5017351585 @default.
- W3087568978 hasAuthorship W3087568978A5017941291 @default.
- W3087568978 hasAuthorship W3087568978A5018176440 @default.
- W3087568978 hasAuthorship W3087568978A5020075019 @default.
- W3087568978 hasAuthorship W3087568978A5021660017 @default.
- W3087568978 hasAuthorship W3087568978A5022193491 @default.
- W3087568978 hasAuthorship W3087568978A5033639682 @default.
- W3087568978 hasAuthorship W3087568978A5037140847 @default.
- W3087568978 hasAuthorship W3087568978A5040975337 @default.
- W3087568978 hasAuthorship W3087568978A5042675351 @default.
- W3087568978 hasAuthorship W3087568978A5050573989 @default.
- W3087568978 hasAuthorship W3087568978A5056623428 @default.